期刊文献+

血乳酸、乳酸清除率和氧合指数对重症脓毒症患者预后评估的临床价值 被引量:2

Prognostic value of blood lactic acid, lactic acid clearance and oxygenation index for patients with severe sepsis
暂未订购
导出
摘要 目的 探讨血乳酸、乳酸清除率和氧合指数在重症脓毒症患者预后评估中的临床价值.方法 选择46例因重症脓毒症入住ICU的患者,按照28d预后分为生存组和死亡组.比较两组血乳酸浓度、乳酸清除率、氧合指数和急性生理与慢性健康状况(APACHEⅡ)评分,并建立ROC曲线.结果 乳酸、乳酸清除率、氧合指数和APACHEⅡ评分在两组患者中差异均有统计学意义(P<0.05或0.01),乳酸、乳酸清除率、氧合指数与APACHEⅡ评分存在明显正相关(r=0.932,P=0.012).乳酸、乳酸清除率、氧合指数阳性项目越多,28d病死率越高.乳酸、乳酸清除率、氧合指数和APACHEⅡ评分的ROC曲线下面积分别为0.715、0.744、0.701、0.759.结论 血乳酸浓度、乳酸清除率和氧合指数与APACHEⅡ评分显著相关,可以预测重症脓毒症患者的预后. Objective To investigate the value of blood lactic acid, lactic acid clearance and oxygenation index in prog- nosis of patients with severe sepsis. Methods Forty-six patients were divided into survival group and death group according to their outcome. Levels of blood lactic acid, lactic acid clearance and oxygenation index were measured, and acute physiology and chronic health evaluation (APACHE Ⅱ) was scored. ROC was constructed to observe the clinical value of blood lactic acid, lactic acid clearance, oxygenation index and APACHE Ⅱ on prognosis of severe sepsis. Results There were significant differences in the levels of blood lactic acid, lactic acid clearance, oxygenation index and APACHE Ⅱ score between two groups. Blood lactic acid, lactic acid clearance and oxygenation index were significantly correlated with APACHE Ⅱ score. The presence of more pos- itive biomarkers, the higher 28-d mortality was. The area under the curve(AUC) in ROC of blood lactic acid, lactic acid clearance, oxygenation index and APACHE Ⅱ score were 0.715, 0.744, 0.701 and 0.759. Conclusion Blood lactic acid, lactic acid clearance and oxygenation index are correlated with APACHE Ⅱ, and can be used for prognosis of patients with severe sepsis.
出处 《浙江医学》 CAS 2012年第9期700-701,704,共3页 Zhejiang Medical Journal
基金 浙江省医药卫生科学研究基金资助项目(2009A017)
关键词 重症脓毒症 血乳酸 乳酸清除率 氧合指数 APACHEⅡ Severe sepsis Lactic acid Lactate clearance rate Oxygenation index Acute physiology and chronic health evaluation
  • 相关文献

参考文献9

  • 1Dellinger R P,Levy M M,Carlet J M. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Critical Care Medicine,2008,(01):296-327.doi:10.1097/01.CCM.0000298158.12101.41.
  • 2Knaus W A,Zimmerman J E,Wagner D P. APACHE-acute physiology and chronic health evaluation:a physiologically based classification system[J].Critical Care Medicine,1981,(08):591-597.doi:10.1097/00003246-198108000-00008.
  • 3龚仕金,陈进,李莉,严静,戴海文,蔡国龙,许强宏.连续右心容量监测指导感染性休克的液体复苏[J].中华急诊医学杂志,2009,18(11):1207-1210. 被引量:12
  • 4Rhodes A,Bennett E D. Early goal-directed therapy:an evidence-based review[J].Critical Care Medicine,2004,(11 Suppl):S448-S450.
  • 5Kobayashi S,Gando S,Morimoto Y. Serial measurement of arterial lactate concentrations as a prognostic indicator in relation to the incidence of disseminated intravascular coagulation in patients with systemic inflammatory response syndrome[J].Surgery Today(Japanese Journal of Surgery ),2001,(10):853-859.
  • 6Levraut J,Ichai C,Petit I. Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients[J].Critical Care Medicine,2003,(03):705-710.doi:10.1097/01.CCM.0000045561.85810.45.
  • 7Nguyen H B,Rivers E P,Knoblich B P. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock[J].Critical Care Medicine,2004,(08):1637-1642.doi:10.1097/01.CCM.0000132904.35713.A7.
  • 8Brierley J,Carcillo J A,Choong K. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock:2007 update from the American College of Critical Care Medicine[J].Critical Care Medicine,2009,(02):666-688.doi:10.1097/CCM.0b013e31819323c6.
  • 9江秀清,阙学俊,苏岸华.动态监测D-Dime、动脉血乳酸、纤维蛋白原、氧合指数在小儿脓毒血症的临床意义[J].中国妇幼保健,2011,26(23):3573-3575. 被引量:4

二级参考文献24

共引文献14

同被引文献40

  • 1杨韶华,周佾龙,仝旭亚.动脉血乳酸和早期乳酸清除率对老年脓毒症患者预后判断的价值[J].中国老年学杂志,2014,34(7):1813-1814. 被引量:14
  • 2成人严重感染与感染性休克血流动力学监测及支持指南(草案)[J].中国危重病急救医学,2007,19(3):129-133. 被引量:86
  • 3罗哲,诸杜明,吴肇光.小剂量垂体后叶素治疗难治性休克[J].中国临床医学,2007,14(3):394-395. 被引量:3
  • 4Micek ST, Roubinian N, Heuring T, et al. Before-after study of a standardized hospital order set for the management of septic shock [ J ]. Crit Care Med, 2006,34 ( 11 ) : 2707-2013.
  • 5Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock : 2012 [ J ]. Crit Care Med, 2013,41 ( 2 ) : 580-637.
  • 6Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock [ J ]. N Engl J Med,2001,345 (19) : 1368-1377.
  • 7Gordon AC, Russell JA, Walley KR, et al. The effects of vasopressin on acute kidney injury in septic shock [ J ]. Intensive Care Med,2010,36 ( 1 ) : 83-91.
  • 8Torgersen C, Dunser MW, Wenzel V, et al. Comparing two different arginine vasopressin doses in advanced vasodilatory shock : a randomized, controlled, open-label trial [ J ]. Intensive Care Med,2010,36 ( 1 ) : 57-65.
  • 9梅其炳.垂体后叶素、缩宫素、加压素作用的比较∥金有豫.药理学[M].5版.北京:人民卫生出版社,2001:270.
  • 10Russell JA, Walley KR. Vasopressin and its immune effects in septic shock [ J ]. J Innate Immun, 2010,2 (5) : 446-460.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部